Literature DB >> 1311578

In vitro and in vivo inhibition of rat liver aldehyde dehydrogenase by S-methyl N,N-diethylthiolcarbamate sulfoxide, a new metabolite of disulfiram.

B W Hart1, M D Faiman.   

Abstract

In summary, these data provide the first evidence that DETC-MeSO is a natural metabolite of disulfiram, and a potent inhibitor of rat liver mitochondrial low Km ALDH both in vitro and in vivo. It is therefore proposed that, based upon evidence to date, DETC-MeSO appears to be the chemical species to which disulfiram must be bioactivated, and is the metabolite most likely responsible for disulfiram's inhibition of rat liver mitochondrial low Km ALDH in vivo. Characterization of the properties of DETC-MeSO as the metabolite responsible for disulfiram's action as an ALDH inhibitor is presently in the process of being completed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311578     DOI: 10.1016/0006-2952(92)90555-w

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration.

Authors:  Robert D Winefield; Anthonius A M Heemskerk; Swetha Kaul; Todd D Williams; Michael J Caspers; Thomas E Prisinzano; Elinore F McCance-Katz; Craig E Lunte; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2015-01-25       Impact factor: 3.935

2.  Disulfiram effects on responses to intravenous cocaine administration.

Authors:  Jennifer R Baker; Peter Jatlow; Elinore F McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

3.  Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Roberto Cadeddu; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2011-08-24       Impact factor: 4.530

4.  Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection.

Authors:  Swetha Kaul; Morris D Faiman; Craig E Lunte
Journal:  Electrophoresis       Date:  2011-01       Impact factor: 3.535

5.  LC-MS/MS method for the determination of carbamathione in human plasma.

Authors:  Anthonius A M Heemskerk; Leon van Haandel; Joshua M Woods; Elinore F McCance-Katz; Todd D Williams; John F Stobaugh; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2010-11-02       Impact factor: 3.935

Review 6.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

7.  Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy.

Authors:  Olga M Viquez; Holly L Valentine; David B Friedman; Sandra J Olson; William M Valentine
Journal:  Chem Res Toxicol       Date:  2007-02-27       Impact factor: 3.739

8.  LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma.

Authors:  Swetha Kaul; Todd D Williams; Craig E Lunte; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2009-07-30       Impact factor: 3.935

9.  S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.

Authors:  Morris D Faiman; Swetha Kaul; Shaheen A Latif; Todd D Williams; Craig E Lunte
Journal:  Neuropharmacology       Date:  2013-07-26       Impact factor: 5.250

10.  Inhibition of rat brain and human red cell acetylcholinesterase by thiocarbamate herbicides.

Authors:  Edward A Lock
Journal:  Toxicol Res (Camb)       Date:  2020-08-28       Impact factor: 3.524

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.